No takes yet. Share an insight, caveat, or question.
Biochemical study reveals modified aminoglycosides selectively inhibit bacterial ribosomes over eukaryotic targets, indicating potential for less toxic antibiotic therapies.
Perez‐Fernandez et al. (2014) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: